Cargando…
Simultaneous Inhibition of MEK and Hh Signaling Reduces Pancreatic Cancer Metastasis
Pancreatic cancer, mostly pancreatic ductal adenocarcinoma (PDAC), is one of the most lethal cancer types, with an estimated 44,330 death in 2018 in the US alone. While targeted therapies and immune checkpoint inhibitors have significantly improved treatment options for patients with lung cancer and...
Autores principales: | Gu, Dongsheng, Lin, Hai, Zhang, Xiaoli, Fan, Qipeng, Chen, Shaoxiong, Shahda, Safi, Liu, Yunlong, Sun, Jie, Xie, Jingwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266431/ https://www.ncbi.nlm.nih.gov/pubmed/30373214 http://dx.doi.org/10.3390/cancers10110403 |
Ejemplares similares
-
Non-Canonical Hh Signaling in Cancer—Current Understanding and Future Directions
por: Gu, Dongsheng, et al.
Publicado: (2015) -
Regulation of pancreatic cancer metastasis through the Gli2-YAP1 axis via regulation of anoikis
por: Yu, Beiqin, et al.
Publicado: (2022) -
Cell Population Analyses During Skin Carcinogenesis
por: Gu, Dongsheng, et al.
Publicado: (2013) -
Metachronous gastric metastasis from lung primary, with synchronous pancreatic neuroendocrine carcinoma
por: El Hajj, Ihab I., et al.
Publicado: (2018) -
Deciphering the role of hedgehog signaling in pancreatic cancer
por: Gu, Dongsheng, et al.
Publicado: (2016)